Skip to main content

Table 3 Crude onchocerciasis MF prevalence and density in Sierra Leone after five annual rounds of MDA

From: Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone

 

Baseline survey

2010 Epidemiological Evaluation

Percentage reduction (%)

Significance test (P-values)

No. examined

MF prev (%)

AMD-all (mf/snip)

AMD-positive (mf/snip)

No. examined

MF prevalence

(95% CI)

AMD-all (mf/snip)

(95% CI)

AMD-positive (mf/snip)

(95% CI)

MF prev

AMD-all

AMD-positive

MF prev

AMD-all

AMD-positive

Overall

7116

53.09

15.33

28.87

5621

21.12 (20.07–22.20)

1.75 (1.48–2.02)

8.29 (7.07–9.50)

60.22

88.58

71.29

0

0

0

By district

 Bo

1499

54.3

18.91

34.82

1079

25.77 (23.24–28.46)

2.95 (2.11–3.80)

11.46 (8.40–14.53)

52.55

84.4

67.09

0

0

0

 Bombali

368

57.88

16.85

29.1

494

16.19 (13.21–19.70)

1.58 (0.86–2.29)

9.72 (5.71–13.72)

72.02

90.62

66.6

0

0

0

 Bonthe

180

40.56

7

17.25

165

26.67 (20.51–33.16)

3.05 (0.41–5.68)

11.42 (1.71–21.13)

34.25

56.43

33.8

0.009

0.004

0.247

 Kailahun

183

49.73

12.06

24.25

118

23.73 (16.96–32.16)

2.01 (0.47–3.55)

8.46 (2.31–14.62)

52.28

83.33

65.11

0

0

0

 Kambia

155

61.94

17.8

28.73

98

23.47 (16.18–32.76)

1.04 (0.43–1.65)

4.41 (2.24–6.58)

62.11

94.16

84.65

0

0

0

 Kenema

286

45.12

6.51

14.42

101

20.79 (14.02–29.70)

1.35 (0.18–2.51)

6.48 (1.09–11.86)

53.9

79.26

55.06

0

0

0.217

 Koinadugu

168

58.33

18.38

31.51

58

6.90 (2.71–16.43)

0.05 (0.00–0.11)

0.75 (0.00–1.55)

88.18

99.73

97.62

0

0

0.005

 Kono

1105

39.01

14.63

37.48

521

9.02 (6.85–11.79)

0.32 (0.18–0.46)

3.53 (2.31–4.75)

76.87

97.81

90.58

0

0

0

 Moyamba

1055

58.2

12.06

20.74

988

29.96 (27.19–32.89)

1.64 (1.27–2.01)

5.46 (4.35–6.58)

48.52

86.4

73.67

0

0

0

 Port Loko

653

57.12

13.83

24.21

738

26.02 (22.98–29.30)

3.10 (1.80–4.40)

11.91 (7.12–16.71)

54.45

77.58

50.81

0

0

0

 Pujehun

560

53.57

9.84

18.36

348

7.76 (5.39–11.03)

0.60 (0.06–1.14)

7.76 (1.03–14.49)

85.52

93.9

57.73

0

0

0.002

 Tonkolili

904

60.4

22.09

36.5

913

16.10 (13.86–18.63)

0.67 (0.43–0.91)

4.16 (2.81–5.50)

73.34

96.97

88.6

0

0

0

By sex

 Male

3461

55.19

21.11

38.16

2805

24.49 (22.94–26.12)

2.55 (2.04–3.06)

10.40 (8.43–12.36)

54.24

87.92

72.75

0

0

0

 Female

3655

51.11

9.94

19.38

2816

17.76 (16.39–19.21)

0.96 (0.77–1.15)

5.40 (4.40–6.40)

64.12

90.34

72.14

0

0

0

Age groups

 1–9

2182

11.05

0.91

8.24

1930

1.71 (1.22–2.39)

0.04 (0.02–0.06)

2.47 (1.49–3.45)

82.55

95.6

70.02

0

0.168

0.02

 10–19

1317

50.57

6.91

13.67

889

16.09 (13.82–18.65)

0.80 (0.51–1.08)

4.94 (3.31–6.58)

66.4

88.42

63.86

0

0

0

 20–29

780

78.21

19.94

25.5

648

38.27 (34.61–42.07)

3.68 (2.48–4.88)

9.58 (6.58–12.58)

49.09

81.54

62.43

0

0

0

 30–39

824

80.95

28.88

35.64

624

37.18 (33.48–41.04)

3.49 (2.34–4.64)

9.38 (6.43–12.33)

52.41

87.92

73.68

0

0

0

 40–49

735

82.31

35.94

43.66

542

38.75 (34.74–42.91)

4.09 (2.65–5.54)

10.56 (6.99–14.13)

51.2

88.62

75.81

0

0

0

 50–59

575

81.39

30.37

37.31

416

37.02 (32.52–41.76)

2.61 (1.15–4.06)

7.04 (3.18–10.89)

52.55

91.41

81.13

0

0

0

  ≥ 60

684

76.17

21.58

28.34

566

29.33 (25.73–33.21)

2.10 (1.47–2.73)

7.17 (5.22–9.12)

59.74

90.27

74.7

0

0

0